Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Listed Suppliers
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2,3-diphenyl-2-cyclopropen-1-one
2. Diphencyprone
3. Diphenylcyclopropenone Monohydrate
1. 886-38-4
2. Diphencyprone
3. 2,3-diphenylcycloprop-2-en-1-one
4. 2,3-diphenylcycloprop-2-enone
5. 2,3-diphenylcyclopropenone
6. 1,2-diphenylcyclopropen-3-one
7. 2-cyclopropen-1-one, 2,3-diphenyl-
8. Cyclopropenone, Diphenyl-
9. Dpcp
10. 2,3-diphenyl-2-cyclopropen-1-one
11. Cyclopropenone, 2,3-diphenyl-
12. Chebi:53074
13. Mfcd00001311
14. I7g14nw5ec
15. Diphenylcycloprop-2-en-1-one
16. Nsc-57541
17. Ncgc00166113-01
18. Dsstox_cid_26545
19. Dsstox_rid_81708
20. Dsstox_gsid_46545
21. Cas-886-38-4
22. Smr000449319
23. Einecs 212-948-4
24. Nsc 57541
25. Unii-i7g14nw5ec
26. Cpd000449319
27. Diphenylcyclopenone
28. Maybridge1_002005
29. Diphencyprone [mi]
30. Cyclopropenone,3-diphenyl-
31. Epitope Id:113236
32. 2,3-diphenyl Cyclopropenone
33. Diphenylcyclopropenone, 98%
34. Mls000758252
35. Mls001424007
36. Diphencyprone [mart.]
37. Schembl105663
38. Diphencyprone [who-dd]
39. Chembl1373467
40. Dtxsid2046545
41. Hms547d03
42. Amy1261
43. 2-cyclopropen-1-one,3-diphenyl-
44. Hms2051i09
45. Hms2231a10
46. Hms3393i09
47. Nsc57541
48. Tox21_112322
49. 2,3-diphenyl-2-cyclopropene-1-one
50. 2,3-diphenyl-cycloprop-2-en-1-one
51. Ccg-55613
52. Geo-01240
53. Stk289679
54. Akos005257686
55. Tox21_112322_1
56. Cs-w015321
57. Db12173
58. Hy-w014605
59. Nc00029
60. Ps-4199
61. Sb17263
62. Ncgc00166113-02
63. Ncgc00166113-04
64. Sy061804
65. Ft-0625256
66. F17153
67. A861627
68. Ad-310/30361065
69. Diphenylcyclopropenone, Purum, >=98.0% (hplc)
70. Q5279743
71. Sr-01000644630-1
72. W-200519
Molecular Weight | 206.24 g/mol |
---|---|
Molecular Formula | C15H10O |
XLogP3 | 3.3 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 1 |
Rotatable Bond Count | 2 |
Exact Mass | 206.073164938 g/mol |
Monoisotopic Mass | 206.073164938 g/mol |
Topological Polar Surface Area | 17.1 Ų |
Heavy Atom Count | 16 |
Formal Charge | 0 |
Complexity | 284 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
NDC Package Code : 73164-0001
Start Marketing Date : 2019-06-30
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 51927-1668
Start Marketing Date : 2002-07-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
Market Place
Reply
26 Feb 2019
ABOUT THIS PAGE
35
PharmaCompass offers a list of Diphencyprone API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Diphencyprone manufacturer or Diphencyprone supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Diphencyprone manufacturer or Diphencyprone supplier.
PharmaCompass also assists you with knowing the Diphencyprone API Price utilized in the formulation of products. Diphencyprone API Price is not always fixed or binding as the Diphencyprone Price is obtained through a variety of data sources. The Diphencyprone Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Diphencyprone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Diphencyprone, including repackagers and relabelers. The FDA regulates Diphencyprone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Diphencyprone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Diphencyprone supplier is an individual or a company that provides Diphencyprone active pharmaceutical ingredient (API) or Diphencyprone finished formulations upon request. The Diphencyprone suppliers may include Diphencyprone API manufacturers, exporters, distributors and traders.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Diphencyprone as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Diphencyprone API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Diphencyprone as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Diphencyprone and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Diphencyprone NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Diphencyprone suppliers with NDC on PharmaCompass.
Diphencyprone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Diphencyprone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Diphencyprone GMP manufacturer or Diphencyprone GMP API supplier for your needs.
A Diphencyprone CoA (Certificate of Analysis) is a formal document that attests to Diphencyprone's compliance with Diphencyprone specifications and serves as a tool for batch-level quality control.
Diphencyprone CoA mostly includes findings from lab analyses of a specific batch. For each Diphencyprone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Diphencyprone may be tested according to a variety of international standards, such as European Pharmacopoeia (Diphencyprone EP), Diphencyprone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Diphencyprone USP).